Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00911885 · ClinicalTrials.gov registry record · NA

A Simple Dietary Message to Improve Dietary Quality for Metabolic Syndrome

A NA study of Metabolic Syndrome, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT00911885: Completed NA study of Metabolic Syndrome, sponsored by University of Massachusetts, Worcester.

NCT00911885 is a NA study of Metabolic Syndrome that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 240 participants, below the 1,203-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00911885, a NA study of Metabolic Syndrome, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

Identifying a simple dietary recommendation for weight loss and metabolic health may demonstrate potential for a simple public health message to impact coronary heart disease (CHD) prevention and metabolic syndrome. In a randomized clinical trial, the investigators propose to compare the efficacy of two intervention approaches to dietary change for CHD prevention among persons with metabolic syndrome. The two approaches are 1) the AHA Dietary Guidelines; and 2) a simple dietary change condition that focuses on increasing fiber. The investigators hypothesize that a message promoting high fiber intake may be the simple message that has potential to produce broad impact.

Conditions Studied

Interventions

  • BEHAVIORAL Dietary Intervention

Study Locations (1)

Massachusetts

  • University of Massachusetts Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2009-04
Est. Completion 2015-03
Phase NA

What the finished NCT00911885 record still lists

NCT00911885 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,203-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Dietary Intervention is the first listed.

NCT00911885 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00911885 about?

NCT00911885 is a clinical study titled "A Simple Dietary Message to Improve Dietary Quality for Metabolic Syndrome". Identifying a simple dietary recommendation for weight loss and metabolic health may demonstrate potential for a simple public health message to impact coronary heart disease (CHD) prevention and metabolic syndrome. In a randomized clinical trial, the investigators propose to compare the efficacy of...

What is the current status of trial NCT00911885?

This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2009-04. Estimated completion is 2015-03.

What conditions does trial NCT00911885 study?

This clinical trial studies the following conditions: Metabolic Syndrome.

What interventions are being tested in trial NCT00911885?

The interventions under investigation include: Dietary Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00911885?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00911885 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00911885's enrollment target sits among peer trials

240 19th of 102 higher than 84 of 102 other Metabolic Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00911885, the US trial registry maintained by the National Library of Medicine. NCT00911885 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.